Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthSource vs Trinity Meds

HealthSource
Graded #97

Higher grade

vs+10
Trinity Meds
Graded #302

Lower grade

The verdict

HealthSource takes it — 71.2/100 to 61.2/100.

HealthSource grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthSource +2
66
64
Dose & formulationHealthSource +19
83
64
Clinical oversightHealthSource +6
80
74
Labs & monitoringHealthSource +2
54
52
FulfillmentHealthSource +12
80
68
Contract termsHealthSource +35
55
20
HealthSource · left barTrinity Meds · right bar

The numbers

MetricHealthSourceTrinity Meds
WeighScore71.2/10061.2/100
GradeCC
Scorecard rank#97#302
Semaglutide$199/mo (all doses, compounded)$149/mo (compounded)
Tirzepatide$299/mo (all doses, compounded)$199/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
HealthSource

Graded #97 · C

Strengths

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

Where it loses points

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical
Trinity Meds

Graded #302 · C

Strengths

  • All-inclusive flat pricing — $149/month semaglutide, same price at every dose, no hidden fees
  • Multi-month plans cut the cost further (semaglutide to $129/month, tirzepatide to $149/month)
  • No insurance required, FSA eligible, with free shipping to your door
  • Named operating entity (Trinity Meds Inc) and US-licensed clinicians via CareValidate Health

Where it loses points

  • Doesn't publish the states it serves — you only learn eligibility after starting the assessment
  • Pharmacy partners are described as 'multiple USA certified pharmacies' but none are named
  • No terms-of-service page is posted (only a privacy policy)
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
  • Military framing is marketing; the program and pricing are open to anyone who qualifies

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard